Abstract
Introduction: The close association of lymphatic and blood vessels and their coordinated development in vivo suggest that some molecules may control both hemangiogenesis and lymphangiogenesis. We have previously shown that the inhibition of Src tyrosine kinase by AZM475271 (AstraZeneca) inhibited hemangiogenesis and suppressed L3.6pl pancreatic tumor growth via induction of tumor endothelial cell apoptosis in mice bearing L3.6pl human pancreatic cancer, but so far there is no evidence about the involvement of Src kinase in lymphangiogenesis and metastatic spread via the lymphatics. We hypothesized that Src tyrosine kinase inhibitors may also generate inhibitory effects on lymphatics, thus, may act as anti-lymphangiogenic agents as well. Material and Methods: Lymphatic endothelial cells (LECs) were isolated by magnetic bead sorting from human dermal microvascular endothelial cells and the purity of isolated LECs exceeded 95 %. Using Western Blot we investigated the ability of the well known Src kinase inhibitor, PP2 (Calbiochem), to block Src kinase activity in the LECs stimulated with VEGF-C. The effect of PP2 on VEGF-C driven proliferation of the LECs was tested in the MTT Proliferation Assay. To investigate the complex process of lymphangiogenesis in vitro, we used a spheroid angiogenesis model. The level of VEGF-C in the supernatant of L3.6pl pancreatic carcinoma cell line was measured by ELISA. We also investigated the migratory activity of isolated LECs following treatment with Src inhibitor using a modified Boyden Chamber Assay. To selectively investigate lymphangiogenesis in vivo, we used the Matrigel Plug Assay and the ingrowth of lymphatic vessels was visualized by LYFE-1 immunostaining. Results: VEGF-C exhibited an increased activity of Src tyrosine kinase in isolated LECs, however the activity was abrogated by treatment with Src kinase inhibitor PP2 in a dose dependent manner. Src kinase inhibitor PP2 also reduced VEGF-C-driven proliferation of isolated LECs in a concentration dependent manner in the MTT Proliferation Assay. PP2 inhibited sprouting of VEGF-C-stimulated LECs in the spheroid assay at even lower concentrations than suggested by the MTT Assay. Src kinase inhibition by PP2 markedly reduced the VEGF-C levels in the supernatant of the highly metastatic pancreatic carcinoma cell line L3.6pl. Inhibition of Src kinase by PP2 also resulted in a significant reduction of the migratory activity of isolated LECs. Lymphatic neovascularization was markedly inhibited in PP2-treated compared to untreated animals in the Matrigel Plug Assay. Conclusion: The Src kinase inhibitor PP2 shows strong anti-lymphangiogenic activity in vitro and in vivo. The combined anti-angiogenic and antilymphangiogenic effects of Src kinase inhibition may provide therapeutic value for the treatment of angiogenesis-dependent diseases and tumor metastasis.
This is a preview of subscription content, log in via an institution.
Buying options
Tax calculation will be finalised at checkout
Purchases are for personal use only
Learn about institutional subscriptionsLiteratur
Yezhelyev MV, Koehl G, Guba M, Brabletz T, Jauch KW, Ryan A, Barge A, Green T, Fennell M, Bruns CJ (2004) Inhibition of SRC tyrosine kinase as treatment for human pancreatic cancer growing orthotopically in nude mice. Clin Cancer Res 1;10(23): 8028–8036
Mäkinen T, Veikkola T, Mustjoki S, Karpanen T, Catimel B, Nice E, Wise L, Mercer A, Kowalski H, Kerjaschki D, Stacker S, Achen M, Alitalo K (2001) Isolated lymphatic endothelial cells transduce growth, survival and migratory signals via the VEGF-C/D receptor VEGFR-3. The EMBO Journal 20: 4762–4773
Salven P, Lymboussaki A, Heikkilä P, Jääskela-Saari H, Enholm B, Aase K, von Euler G, Eriksson U, Alitalo K, Joensuu H (1998) Vascular Endothelial Growth Factors VEGF-B and VEGF-C are expressed in human tumors. Am J Pathol 153(1): 103–108
Cao Y, Linden P, Farnebo J, Cao R, Eriksson A, Kumar V, Qi J, Claesson-Welsh L, Alitalo K (1998) Vascular endothelial growth factor C induces angiogenesis in vivo. Proc Natl Acad Sci USA 24; 95(24): 14389–14394
Alitalo K, Tammela T, Petrova TV (2005) Lymphangiogenesis in development and human disease. Nature 15; 438(7070): 946–953
Author information
Authors and Affiliations
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2007 Springer Medizin Verlag Heidelberg
About this paper
Cite this paper
Ischenko, I., Huber, S., Guba, M., Heeschen, C., Jauch, K.W., Bruns, C.J. (2007). Bedeutung der Familien der Src Tyrosinkinasen in der Lymphangiogenese. In: Steinau, H.U., Schackert, H.K., Bauer, H. (eds) Chirurgisches Forum 2007. Deutsche Gesellschaft für Chirurgie, vol 36. Springer, Berlin, Heidelberg. https://doi.org/10.1007/978-3-540-71123-0_28
Download citation
DOI: https://doi.org/10.1007/978-3-540-71123-0_28
Publisher Name: Springer, Berlin, Heidelberg
Print ISBN: 978-3-540-71122-3
Online ISBN: 978-3-540-71123-0
eBook Packages: Medicine (German Language)